aztreonam has been researched along with cefdinir in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Akasaka, S; Inatomi, H; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
Årdal, C; Hudson, J; Kållberg, C; Klein, E; Laxminarayan, R; Lindbæk, M; Outterson, K; Røttingen, JA; Salvesen Blix, H | 1 |
1 review(s) available for aztreonam and cefdinir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for aztreonam and cefdinir
Article | Year |
---|---|
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
Topics: Adult; Anti-Infective Agents; Aztreonam; Cefdinir; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Neisseria gonorrhoeae; Roxithromycin; Spectinomycin; Urethritis | 2001 |
The effect of generic market entry on antibiotic prescriptions in the United States.
Topics: Anti-Bacterial Agents; Aztreonam; Cefdinir; Cefprozil; Cephalosporins; Costs and Cost Analysis; Databases, Pharmaceutical; Drug Costs; Drug Industry; Drug Prescriptions; Drugs, Generic; Humans; United States | 2021 |